Urticaria Activity Score (UAS)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
uas7 score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Urticaria-free0–0
  • Well-controlled1–6
  • Mild7–15
  • Moderate16–27
Direct Clinical Answer

The Urticaria Activity Score (UAS) calculates quantifying total body surface area involvement and staging cutaneous or blistering disease severity. Key inputs include day1 wheals. Scores guide calculating resuscitation fluid protocols, administering topical or systemic corticosteroids, and wound care. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Stratifies severity of urticaria through diary-based assessment of wheals and itch intensity. The UAS7 score (weekly score) is calculated by summing daily scores over 7 consecutive days, providing a standardized measure for chronic spontaneous urticaria activity monitoring and treatment response assessment.

Clinical Indication

The Urticaria Activity Score (UAS) is indicated for bedside clinical practice to support Stratifies severity of urticaria through diary-based assessment of wheals and itch intensity. The UAS7 score (weekly score) is calculated by summing daily scores over 7 consecutive days, providing a standardized measure for chronic spontaneous urticaria activity monitoring and treatment response assessment.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute thermal burns, extensive bullous eruptions, severe psoriasis, or severe cutaneous adverse reactions. Clinical application is indicated across Dermatology clinics, burn centers, and emergency dermatology triage.

Limitations & Contraindications

Rule of Nines overestimates burn surface area in pediatric anatomy; Lund-Browder charts must be utilized.

Clinical Pearls & Action Plan

Full-body cutaneous examination including all mucous membranes and scalp is necessary to detect early epidermal detachment. Guideline pearl: A cutoff of UAS7 ≥11 has shown sensitivity of 74% and specificity of 86% for identifying active disease.

Formula & Variables:

UAS7 = Σ(daily wheals score + daily itch score) over 7 consecutive days

Input Parameters

NameTypeRequiredDescription
day1_whealsintegerYesDay 1 - Number of wheals (hives) in past 24 hours(points)
day1_itchintegerYesDay 1 - Itch intensity in past 24 hours(points)
day2_whealsintegerYesDay 2 - Number of wheals (hives) in past 24 hours(points)
day2_itchintegerYesDay 2 - Itch intensity in past 24 hours(points)
day3_whealsintegerYesDay 3 - Number of wheals (hives) in past 24 hours(points)
day3_itchintegerYesDay 3 - Itch intensity in past 24 hours(points)
day4_whealsintegerYesDay 4 - Number of wheals (hives) in past 24 hours(points)
day4_itchintegerYesDay 4 - Itch intensity in past 24 hours(points)
day5_whealsintegerYesDay 5 - Number of wheals (hives) in past 24 hours(points)
day5_itchintegerYesDay 5 - Itch intensity in past 24 hours(points)
day6_whealsintegerYesDay 6 - Number of wheals (hives) in past 24 hours(points)
day6_itchintegerYesDay 6 - Itch intensity in past 24 hours(points)
day7_whealsintegerYesDay 7 - Number of wheals (hives) in past 24 hours(points)
day7_itchintegerYesDay 7 - Itch intensity in past 24 hours(points)

Score Interpretation & Guidance

RangeStageDescription
0–0Urticaria-freeNo urticaria activity
1–6Well-controlledVery mild urticaria activity
7–15MildMild urticaria activity
16–27ModerateModerate urticaria activity
28–42SevereSevere urticaria activity

Evidence-Based References (EBM)

  • Młynek A, Zalewska-Janowska A, Martus P, et al. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63(6):777-780.
  • Hawro T, Ohanyan T, Schoepke N, et al. The Urticaria Activity Score--Validity, Reliability, and Responsiveness. J Allergy Clin Immunol Pract. 2018;6(4):1185-1190.e1.
  • Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA²LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2014 revision. Allergy. 2014;69(7):868-887.

Related calculators